2023 annual financial data
Corcept Therapeutics 2023 Operating margin
Corcept Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was 22.24%.
Operating income was 107,282,000 USD and net income was 106,140,000 USD.
Operating cash flow was 127,039,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 482,375,000 USD
- Operating income
- 107,282,000 USD
- Net income
- 106,140,000 USD
- Operating cash flow
- 127,039,000 USD